Comparative Analysis of Clinical and Laboratory Parameters of Autoimmune and Idiopathic Chronic Urticaria Patients
Abstract
Background: According to the cause, chronic urticaria is most frequently divided into autoimmune and idiopathic urticaria. Aim of the paper was to determine the frequency of autoimmune urticaria using autologous serum skin testing and a comparative analysis of chronic idiopathic and chronic autoimmune urticaria by disease course, severity and most common comorbidities.
Methods: Analysis covered 64 adult patients of both sexes with chronic urticaria, divided into two groups according to their positivity in autologous serum skin testing (group I with positive test and group II with negative test). General haematological and biochemical parameters, antithyroid antibodies, hepatitis serum markers, Helicobacter pylori and Borrelia burgdorferi antibodies were performed for patients in both groups. First group patients were treated by autologous blood therapy (autohaemotherapy). The analytical statistical tool SPSS (Statistical Product and Service Solutions) version 20 for descriptive statistics and statistical methods was used. The significance level used was p = 0.05.
Results: The frequency of positive autologous serum test in total population of patients with chronic urticaria was 43.8 %. The average duration of urticaria was 20 months in both groups. Statistically significant difference was found in weekly scores between the studied groups (p = 0.032) in favour of chronic autoimmune urticaria with a positive autologous serum test. Subjects with chronic autoimmune urticaria had a significantly higher association with autoimmune thyroid diseases.
Conclusions: Direct relation was established between the use of autologous blood therapy in patients with autoimmune chronic urticaria and improvement of the clinical picture.
References
1. Saini SS. Chronic spontaneous urticaria: etiology and pathogenesis. Immunol Allergy Clin North Am 2014 Feb;34(1):33-52.
2. Lapi F, Cassano N, Pegoraro V, Cataldo N, Heiman F, Cricelli I, et al. Epidemiology of chronic spontaneous
urticaria: results from a nationwide, population-based study in Italy. Br J Dermatol 2016 May;174(5):996-1004.
3. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. The EAACI/GA(2) LEN/
EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision
and update. Allergy 2014 Jul;69(7):868-87.
4. Criado PR, Criado RFJ, Maruta CW, dos Reis VMS. Chronic urticaria in adults: state-of-the-art in the new
millennium. An Bras de Dermatol 2015;90(1):74–89.
5. Broder MS, Raimundo K, Antonova E, Chang E. Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria. Am J Clin Dermatol 2015;16:313‐21.
6. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013 Jan;68(1):27-36.
7. Beck LA, Bernstein JA, Maurer M. A Review of international recommendations for the diagnosis and management of chronic urticaria. Acta Derm Venereol 2017 Feb 8;97(2):149-58.
8. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity:
associations found in a large population study. J Allergy Clin Immunol 2012 May;129(5):1307-13.
9. Wardhana, Datau EA. Chronic autoimmune urticaria. Acta Med Indones 2012 Apr;44(2):165-74.
10. Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch Dis
Child 2003 Jun;88(6):517-9.
11. Greenberger PA. Chronic urticaria: new management options. World Allergy Organ J 2014 Nov 5;7(1):31. doi:
10.1186/1939-4551-7-31.
12. Konstantinou GN, Asero R, Ferrer M, Knol EF, Maurer M, Raap U, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013 Jan;68(1):27-36.
13. Ferrer M. Immunological events in chronic spontaneous urticaria. Clin Transl Allergy 2015 Aug 25;5:30.
doi: 10.1186/s13601-015-0074-7.
14. Costa C, Gonçalo M; GPEU – Grupo Português de Estudos de Urticária. [Diagnostic and therapeutic approach
of chronic spontaneous urticaria: recommendations in Portugal]. Acta Med Port 2016 Nov;29(11):763-81. Portuguese.
15. Perera E, Sinclair R. Evaluation, diagnosis and management of chronic urticaria. Aust Fam Physician 2014
Sep;43(9):621-5.
16. Maurer M, Church MK, Gonçalo M, Sussman G, Sánchez- Borges M. Management and treatment of chronic
urticaria (CU). J Eur Acad Dermatol Venereol 2015 Jun;29 Suppl 3:16-32.
17. Vestergaard C, Deleuran M. Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and
therapy. Ther Adv Chronic Dis 2015 Nov;6(6):304-13.
18. Godse KV. Autologous serum skin test in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol
2004 Sep-Oct;70(5):283-4.
19. Fusari A, Colangelo C, Bonifazi F, Antonicelli L. The autologous serum skin test in the follow-up of patients
with chronic urticaria. Allergy 2005 Feb;60(2):256-8.
20. Boonpiyathad T, Sangasapaviliya A. Autologous serum and plasma skin test to predict 2-year outcome in
chronic spontaneous urticaria. Asia Pac Allergy 2016 Oct;6(4):226-35.
21. Curto-Barredo L, Yelamos J, Gimeno R, Mojal S, Pujol RM, Giménez-Arnau A. Basophil activation test identifies the patients with chronic spontaneous urticaria suffering the most active disease. Immun Inflamm Dis
2016 Oct 4;4(4):441-5.
22. Vikramkumar AG, Kuruvila S, Ganguly S. Autologous serum skin test as an indicator of chronic autoimmune
urticaria in a tertiary care hospital in South India. Indian Dermatol Online J 2014 Dec;5(Suppl 2):S87-91.
23. Fiebiger E, Maurer D, Holub H, Reininger B, Hartmann G, Woisetschlager M, et al. Serum IgG autoantibodies
directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct
subset of chronic urticaria patients? J Clin Invest 1995 Dec;96(6):2606-12.
24. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic
urticaria--a clinical, immunological and histological evaluation. Br J Dermatol 1986 May;114(5):583-90.
25. Jariwala SP, Moday H, de Asis ML, Fodeman J, Hudes G, de Vos G, et al. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. Ann Allergy Asthma Immunol 2009 Jun;102(6):475-82.
26. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity
in patients with chronic urticaria? Allergy 2008 Jun;63(6):777-80.
27. Mathias SD, Dreskin SC, Kaplan A, Saini SS, Spector S, Rosén KE. Development of a daily diary for patients
with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2010 Aug;105(2):142-8.
28. Moolani Y, Lynde C, Sussman G. Advances in understanding and managing chronic urticaria. F1000Res
2016 Feb 16;5:F1000 Faculty Rev-177. doi: 10.12688/f1000research.7246.1.
29. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute
and chronic urticaria: 2014 update. J Allergy Clin Immunol 2014;133(5):1270-7.
30. Kocatürk E, Maurer M, Metz M, Grattan C. Looking forward to new targeted treatments for chronic spontaneous urticaria. Clin Transl Allergy 2017 Jan 10;7:1. doi:10.1186/s13601-016-0139-2.
31. Bajaj AK, Saraswat A, Upadhyay A, Damisetty R, Dhar S. Autologous serum therapy in chronic urticaria: old
wine in a new bottle. Indian J Dermatol Venereol Leprol 2008;74(2):109-13.
32. Kocatürk E, Aktaş S, Türkoğlu Z, Kavala M, Zindanci I, Koc M, et al. Autologous whole blood and autologous
serum injections are equally effective as placebo injections in reducing disease activity in patients with
chronic spontaneous urticaria: a placebo controlled, randomized, single-blind study. J Dermatolog Treat
2012 Dec;23(6):465-71.
33. Pittler MH, Armstrong NC, Cox A, Collier PM, Hart A, Ernst E. Randomized, double-blind, placebo-controlled
trial of autologous blood therapy for atopic dermatitis. Br J Dermatol 2003 Feb;148(2):307-13.
34. Patil S, Sharma N, Godse K. Autologous serum therapy in chronic urticaria. Indian J Dermatol 2013 May;58(3):225-6.
35. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212(2):150-9.
36. Tseng JTP, Lee WR, Lin SS, Hsu CH, Yang HH, Wang KH, et al. Autologous serum skin test and autologous whole blood injections to patients with chronic urticaria: a retrospective analysis. Dermatol Sinica 2009:27(1):27-
36.
37. Vikramkumar AG, Kuruvila S, Ganguly S. Autologous serum skin test as an indicator of chronic autoimmune
urticaria in a tertiary care hospital in South India. Indian Dermatol Online J 2014 Dec;5(Suppl 2):S87-91.
38. Mozena JD, Adrienne Tińana A, Negri J, John W Steinke JW, Borish L. Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol 2010;130(7):1860–5.
39. Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S. Autologous serum skin test in chronic idiopathic urticaria:
prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 2006 Dec;24(4):201-6.
40. Ghafari J, Kosarian M, Nazari Z, Nabavi M. Relation between chronic urticaria and thyrpid autoimmunity. J
Univ Med Sci 2008;18(63):66-72.
41. George M, Balachandran C, Prabhu S. Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol 2008 Mar-Apr;74(2):105-8.
42. Vohra S, Sharma NL, Mahajan VK. Autologous serum skin test: methodology, interpretation and clinical applications. Indian J Dermatol Venereol Leprol 2009 Sep-Oct;75(5):545-8.
43. Al-Hamamy HR, Hameed AF, Abdulhadi AS. Autologous serum skin test as a diagnostic aid in chronic idiopathic urticaria. ISRN Dermatol 2013 Apr 18;2013:291524. doi: 10.1155/2013/291524.
44. Krupashankar DS, Shashikala K, Madala R. Clinical and investigative assessment of patients with positive
versus negative autologous serum skin test: a study of 80 South Indian patients. Indian J Dermatol 2012
Nov;57(6):434-8.
45. Jáuregui I, Ortiz de Frutos FJ, Ferrer M, Giménez-Arnau A, Sastre J, Bartra J, et al. Assessment of severity and
quality of life in chronic urticaria. J Invest Allergol Clin Immunol 2014;24(2):80-6.
46. Yadav MK, Rishi JP, Nijawan S. Chronic urticaria and Helicobacter pylori. Indian J Med Sci 2008 Apr;62(4):157-
62.
47. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with
Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003;49(5):861-4.
48. Moreira A, Rodrigues J, Delgado L, Fonseca J, Vaz M. Is Helicobacter pylori infection associated with chronic
idiopathic urticaria? Allergol Immunopathol (Madr) 2003 Jul-Aug;31(4):209-14.
49. Heymann WR, Ellis DL. Borrelia burgdorferi Infections in the United States. J Clin Aesthet Dermatol 2012
Aug;5(8):18-28.
50. Staubach P, Vonend A, Burow G, Metz M, Magerl M, Maurer M. Patients with chronic urticaria exhibit increased rates of sensitisation to Candida albicans, but not to common moulds. Mycoses 2009 Jul;52(4):334-8.
51. Ghaffari J, Mohammadzadeh I, Mahdavi MR. Skin prick test with aeroallergens in patients with chronic urticaria. J Babol Univ Med Sci 2012; 14(2):66-72.
52. Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212(2):150-9.
53. Kumar S, Dhillon SS, Brar BK, Singh A. Comparative evaluation of the therapeutic efficacy and safety of
injected histaglobulin versus autologous serum therapy in chronic urticaria. J Clin Aesthet Dermatol 2021 Mar;14(3):38-41.
54. Datta A, Chandra S, Saha A, Sil A, Das NK. Exploring the safety and effectiveness of subcutaneous autologous serum therapy versus conventional intramuscular autologous serum therapy in chronic urticaria: An observer-blind, randomized, controlled study. Indian J Dermatol Venereol Leprol 2020 Nov-Dec;86(6):632-42.
55. Fukuda S, Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004;39:827-30.
56. Khan DA. Chronic urticaria: diagnosis and management. Allergy Asthma Proc 2008 Sep-Oct;29(5):439-46.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).